Anteotech 2023 Webinar - David Radford, page-48

For all of the doubting thomases out there, take a look at the scope of Trinseo's activities and the industries they're associated with.

If Anteo can add value to their existing portfolio, then this has the potential to be an excellent and mutually profitable relationship into the future.
Partnering with the big boys is likely to be a lot more efficient and a speedier pathway to commercialisation than Anteo trying to crack into multiple markets alone.

I applaud the apparent demise of EuGeni as a necessary step in moving on from the previous one dimensional past. If Anteo can leverage it's expertise in mupltiplexing and POC assay development with existing global players, the speed to market for a range of tests should again be expedited.

There's no dollars on the table yet but clearly there will be at least another MOU and or some dollars from govt grants coming to Anteo pretty soon. DR was unequivocal in relation to the former.

Shame the sp didn't hold today but as Gloucester said previously, shareholders are looking for dollars in the bank before committing to the longer term. By the time we get to option conversion in late March I suspect that those who hold on and ride the inevitable sp fluctuations will be glad they did. I bought a few more today prior to the close in anticipation.